Global and United States Biosimilars/follow-on-biologics Market Size, Status and Forecast 2020-2026
Table of Contents1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Human growth hormone
1.2.3 Erythropoietin
1.2.4 Monoclonal antibodies
1.2.5 Insulin
1.2.6 Interferon
1.2.7 Granulocyte-Colony Stimulating Factor
1.2.8 Others
1.3 Market by Application
1.3.1 Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
1.3.2 Blood disorders
1.3.3 Oncology diseases
1.3.4 Chronic and autoimmune diseases
1.3.5 Growth hormone deficiencies
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Biosimilars/follow-on-biologics Market Perspective (2015-2026)
2.2 Global Biosimilars/follow-on-biologics Growth Trends by Regions
2.2.1 Biosimilars/follow-on-biologics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Biosimilars/follow-on-biologics Historic Market Share by Regions (2015-2020)
2.2.3 Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biosimilars/follow-on-biologics Players by Market Size
3.1.1 Global Top Biosimilars/follow-on-biologics Players by Revenue (2015-2020)
3.1.2 Global Biosimilars/follow-on-biologics Revenue Market Share by Players (2015-2020)
3.2 Global Biosimilars/follow-on-biologics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Biosimilars/follow-on-biologics Revenue
3.4 Global Biosimilars/follow-on-biologics Market Concentration Ratio
3.4.1 Global Biosimilars/follow-on-biologics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biosimilars/follow-on-biologics Revenue in 2019
3.5 Key Players Biosimilars/follow-on-biologics Area Served
3.6 Key Players Biosimilars/follow-on-biologics Product Solution and Service
3.7 Date of Enter into Biosimilars/follow-on-biologics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biosimilars/follow-on-biologics Breakdown Data by Type (2015-2026)
4.1 Global Biosimilars/follow-on-biologics Historic Market Size by Type (2015-2020)
4.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Type (2021-2026)
5 Biosimilars/follow-on-biologics Breakdown Data by Application (2015-2026)
5.1 Global Biosimilars/follow-on-biologics Historic Market Size by Application (2015-2020)
5.2 Global Biosimilars/follow-on-biologics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Biosimilars/follow-on-biologics Market Size (2015-2026)
6.2 North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
6.3 North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
6.4 North America Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Biosimilars/follow-on-biologics Market Size (2015-2026)
7.2 Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
7.3 Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
7.4 Europe Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Biosimilars/follow-on-biologics Market Size (2015-2026)
8.2 China Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
8.3 China Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
8.4 China Biosimilars/follow-on-biologics Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Biosimilars/follow-on-biologics Market Size (2015-2026)
9.2 Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
9.3 Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
9.4 Japan Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Biosimilars/follow-on-biologics Market Size (2015-2026)
10.2 Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020)
10.3 Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020)
10.4 Southeast Asia Biosimilars/follow-on-biologics Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Novartis (Sandoz)
11.1.1 Novartis (Sandoz) Company Details
11.1.2 Novartis (Sandoz) Business Overview
11.1.3 Novartis (Sandoz) Biosimilars/follow-on-biologics Introduction
11.1.4 Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020))
11.1.5 Novartis (Sandoz) Recent Development
11.2 Synthon Pharmaceuticals
11.2.1 Synthon Pharmaceuticals Company Details
11.2.2 Synthon Pharmaceuticals Business Overview
11.2.3 Synthon Pharmaceuticals Biosimilars/follow-on-biologics Introduction
11.2.4 Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.2.5 Synthon Pharmaceuticals Recent Development
11.3 Teva Pharmaceutical Industries
11.3.1 Teva Pharmaceutical Industries Company Details
11.3.2 Teva Pharmaceutical Industries Business Overview
11.3.3 Teva Pharmaceutical Industries Biosimilars/follow-on-biologics Introduction
11.3.4 Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.3.5 Teva Pharmaceutical Industries Recent Development
11.4 LG Life Sciences
11.4.1 LG Life Sciences Company Details
11.4.2 LG Life Sciences Business Overview
11.4.3 LG Life Sciences Biosimilars/follow-on-biologics Introduction
11.4.4 LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.4.5 LG Life Sciences Recent Development
11.5 Celltrion Biocon
11.5.1 Celltrion Biocon Company Details
11.5.2 Celltrion Biocon Business Overview
11.5.3 Celltrion Biocon Biosimilars/follow-on-biologics Introduction
11.5.4 Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.5.5 Celltrion Biocon Recent Development
11.6 Hospira
11.6.1 Hospira Company Details
11.6.2 Hospira Business Overview
11.6.3 Hospira Biosimilars/follow-on-biologics Introduction
11.6.4 Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.6.5 Hospira Recent Development
11.7 Merck Serono (Merck)
11.7.1 Merck Serono (Merck) Company Details
11.7.2 Merck Serono (Merck) Business Overview
11.7.3 Merck Serono (Merck) Biosimilars/follow-on-biologics Introduction
11.7.4 Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.7.5 Merck Serono (Merck) Recent Development
11.8 Biogen idec
11.8.1 Biogen idec Company Details
11.8.2 Biogen idec Business Overview
11.8.3 Biogen idec Biosimilars/follow-on-biologics Introduction
11.8.4 Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.8.5 Biogen idec Recent Development
11.9 Genentech (Roche)
11.9.1 Genentech (Roche) Company Details
11.9.2 Genentech (Roche) Business Overview
11.9.3 Genentech (Roche) Biosimilars/follow-on-biologics Introduction
11.9.4 Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020)
11.9.5 Genentech (Roche) Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesTable 1. Global Biosimilars/follow-on-biologics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Human growth hormone
Table 4. Key Players of Erythropoietin
Table 5. Key Players of Monoclonal antibodies
Table 6. Key Players of Insulin
Table 7. Key Players of Interferon
Table 8. Key Players of Granulocyte-Colony Stimulating Factor
Table 9. Key Players of Others
Table 10. Global Biosimilars/follow-on-biologics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 11. Global Biosimilars/follow-on-biologics Market Size by Regions (US$ Million): 2020 VS 2026
Table 12. Global Biosimilars/follow-on-biologics Market Size by Regions (2015-2020) (US$ Million)
Table 13. Global Biosimilars/follow-on-biologics Market Share by Regions (2015-2020)
Table 14. Global Biosimilars/follow-on-biologics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 15. Global Biosimilars/follow-on-biologics Market Share by Regions (2021-2026)
Table 16. Biosimilars/follow-on-biologics Market Market Trends
Table 17. Biosimilars/follow-on-biologics Market Drivers
Table 18. Biosimilars/follow-on-biologics Market Challenges
Table 19. Biosimilars/follow-on-biologics Market Restraints
Table 20. Global Biosimilars/follow-on-biologics Revenue by Players (2015-2020) (US$ Million)
Table 21. Global Biosimilars/follow-on-biologics Market Share by Players (2015-2020)
Table 22. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2019)
Table 23. Global Biosimilars/follow-on-biologics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Biosimilars/follow-on-biologics Product Solution and Service
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 28. Global Biosimilars/follow-on-biologics Market Size Share by Type (2015-2020)
Table 29. Global Biosimilars/follow-on-biologics Revenue Market Share by Type (2021-2026)
Table 30. Global Biosimilars/follow-on-biologics Market Size Share by Application (2015-2020)
Table 31. Global Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 32. Global Biosimilars/follow-on-biologics Market Size Share by Application (2021-2026)
Table 33. North America Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 34. North America Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 35. North America Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 36. North America Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 37. North America Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 38. North America Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 39. Europe Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 40. Europe Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 41. Europe Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 42. Europe Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 43. Europe Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 44. Europe Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 45. China Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 46. China Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 47. China Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 48. China Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 49. China Biosimilars/follow-on-biologics Market Size by Region (US$ Million) (2015-2020)
Table 50. China Biosimilars/follow-on-biologics Market Share by Region (2015-2020)
Table 51. Japan Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 52. Japan Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 53. Japan Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 54. Japan Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 55. Japan Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 56. Japan Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 57. Southeast Asia Biosimilars/follow-on-biologics Market Size by Type (2015-2020) (US$ Million)
Table 58. Southeast Asia Biosimilars/follow-on-biologics Market Share by Type (2015-2020)
Table 59. Southeast Asia Biosimilars/follow-on-biologics Market Size by Application (2015-2020) (US$ Million)
Table 60. Southeast Asia Biosimilars/follow-on-biologics Market Share by Application (2015-2020)
Table 61. Southeast Asia Biosimilars/follow-on-biologics Market Size by Country (US$ Million) (2015-2020)
Table 62. Southeast Asia Biosimilars/follow-on-biologics Market Share by Country (2015-2020)
Table 63. Novartis (Sandoz) Company Details
Table 64. Novartis (Sandoz) Business Overview
Table 65. Novartis (Sandoz) Product
Table 66. Novartis (Sandoz) Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 67. Novartis (Sandoz) Recent Development
Table 68. Synthon Pharmaceuticals Company Details
Table 69. Synthon Pharmaceuticals Business Overview
Table 70. Synthon Pharmaceuticals Product
Table 71. Synthon Pharmaceuticals Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 72. Synthon Pharmaceuticals Recent Development
Table 73. Teva Pharmaceutical Industries Company Details
Table 74. Teva Pharmaceutical Industries Business Overview
Table 75. Teva Pharmaceutical Industries Product
Table 76. Teva Pharmaceutical Industries Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 77. Teva Pharmaceutical Industries Recent Development
Table 78. LG Life Sciences Company Details
Table 79. LG Life Sciences Business Overview
Table 80. LG Life Sciences Product
Table 81. LG Life Sciences Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 82. LG Life Sciences Recent Development
Table 83. Celltrion Biocon Company Details
Table 84. Celltrion Biocon Business Overview
Table 85. Celltrion Biocon Product
Table 86. Celltrion Biocon Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 87. Celltrion Biocon Recent Development
Table 88. Hospira Company Details
Table 89. Hospira Business Overview
Table 90. Hospira Product
Table 91. Hospira Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 92. Hospira Recent Development
Table 93. Merck Serono (Merck) Company Details
Table 94. Merck Serono (Merck) Business Overview
Table 95. Merck Serono (Merck) Product
Table 96. Merck Serono (Merck) Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 97. Merck Serono (Merck) Recent Development
Table 98. Biogen idec Business Overview
Table 99. Biogen idec Product
Table 100. Biogen idec Company Details
Table 101. Biogen idec Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 102. Biogen idec Recent Development
Table 103. Genentech (Roche) Company Details
Table 104. Genentech (Roche) Business Overview
Table 105. Genentech (Roche) Product
Table 106. Genentech (Roche) Revenue in Biosimilars/follow-on-biologics Business (2015-2020) (US$ Million)
Table 107. Genentech (Roche) Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of FiguresFigure 1. Global Biosimilars/follow-on-biologics Market Share by Type: 2020 VS 2026
Figure 2. Human growth hormone Features
Figure 3. Erythropoietin Features
Figure 4. Monoclonal antibodies Features
Figure 5. Insulin Features
Figure 6. Interferon Features
Figure 7. Granulocyte-Colony Stimulating Factor Features
Figure 8. Others Features
Figure 9. Global Biosimilars/follow-on-biologics Market Share by Application: 2020 VS 2026
Figure 10. Blood disorders Case Studies
Figure 11. Oncology diseases Case Studies
Figure 12. Chronic and autoimmune diseases Case Studies
Figure 13. Growth hormone deficiencies Case Studies
Figure 14. Others Case Studies
Figure 15. Biosimilars/follow-on-biologics Report Years Considered
Figure 16. Global Biosimilars/follow-on-biologics Market Size (US$ Million), YoY Growth 2015-2026
Figure 17. Global Biosimilars/follow-on-biologics Market Share by Regions: 2020 VS 2026
Figure 18. Global Biosimilars/follow-on-biologics Market Share by Regions (2021-2026)
Figure 19. Global Biosimilars/follow-on-biologics Market Share by Players in 2019
Figure 20. Global Top Biosimilars/follow-on-biologics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Biosimilars/follow-on-biologics as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Biosimilars/follow-on-biologics Revenue in 2019
Figure 22. North America Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. United States Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Canada Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Europe Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. Germany Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. France Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. U.K. Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Italy Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. Russia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Nordic Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Europe Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. China Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Japan Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. South Korea Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Southeast Asia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. India Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. Australia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Asia-Pacific Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Latin America Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 42. Mexico Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 43. Brazil Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 44. Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 45. Turkey Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 46. Saudi Arabia Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 47. UAE Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 48. Rest of Middle East & Africa Biosimilars/follow-on-biologics Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 49. Novartis (Sandoz) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 50. Synthon Pharmaceuticals Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 51. Teva Pharmaceutical Industries Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 52. LG Life Sciences Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 53. Celltrion Biocon Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 54. Hospira Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 55. Merck Serono (Merck) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 56. Biogen idec Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 57. Genentech (Roche) Revenue Growth Rate in Biosimilars/follow-on-biologics Business (2015-2020)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed